HIV/TB Co-Ordination Program – An Integration in Highly Epidemic Provinces


Year : 2025 | Volume : 15 | 02 | Page : –
    By

    Arish Mohammad Khan Sherwani,

  • Rehmatulla,

  • Basvaraj Bagli,

  • Syed Mohammad Safdar Ashraf,

  1. Professor and HOD, Tahaffuzi wa Samaji Tib [Community Medicine (Unani)], National Institute of Unani Medicine, Bangalore, Karnataka, India
  2. Chief Medical Officer, Government Unani College & Hospital, Government of Karnataka Basveshwara Nagar, Bangaluru, Karnataka, India
  3. Professor, Department of Ain Uzn Anaf wo Halaq [Eye, ENT Unani), Government Unani Medical College, Bangalore, Karnataka, India
  4. Professor, Department of Tahaffuzi wa Samaji Tib, Faculty of Unani Medicine at Aligarh Muslim University,Aligarh, Uttar Pradesh, India

Abstract

document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_abs_176175’);});Edit Abstract & Keyword

Tuberculosis is the commonest co-infection among PLHA (HIV/AIDS). An appropriate measure for controlling TB spread in community of high TB/HIV burden state that requires intervention strategies against this dual epidemic which include intensified case finding at ART centers, involvement of health care delivery system, and Non-Government Organizations for early detection of TB and HIV, counselling and support, provision of daily patient’s weight band-wise FDD, ATT for TB, cotrimoxazole preventive/ prophylaxis therapy (CPT) and Highly active anti-Retro viral Treatment (HAART) at the integrated centres.

Keywords: HAART (Highly active anti-retroviral therapy), FDD, ICTC, VCTC

How to cite this article:
Arish Mohammad Khan Sherwani, Rehmatulla, Basvaraj Bagli, Syed Mohammad Safdar Ashraf. HIV/TB Co-Ordination Program – An Integration in Highly Epidemic Provinces. Research and Reviews: A Journal of Microbiology and Virology. 2025; 15(02):-.
How to cite this URL:
Arish Mohammad Khan Sherwani, Rehmatulla, Basvaraj Bagli, Syed Mohammad Safdar Ashraf. HIV/TB Co-Ordination Program – An Integration in Highly Epidemic Provinces. Research and Reviews: A Journal of Microbiology and Virology. 2025; 15(02):-. Available from: https://journals.stmjournals.com/rrjomv/article=2025/view=0


document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_ref_176175’);});Edit

References

  1. National AIDS Control Organization | MoHFW | GoI [Internet]. Naco.gov.in. 2017. Available from: https://naco.gov.in/
  2. National Aids Prevention and Control Policy [Internet]. Available from: https://www.naco.gov.in/sites/default/files/NationalAIDSContyrol%26PreventionPolicy2002.pdF
  3. Hussain T, Sinha S, Kulshreshtha KK, Yadav VS, Sharma P, Sengupta U, Katoch VM. Seroprevalence of HIV infection among tuberculosis patients in Agra, India—a hospital-based study. Tuberculosis. 2006 Jan 1;86(1):54-9.
  4. Jain SK, Aggarwal JK, Rajpal S, Baveja U. Prevalence of HIV infection among tuberculosis patients in Delhi-A sentinel surveillance study. Indian J Tuberc. 2000 Sep 27;47(21):21-6.
  5. Sharma SK, Saha PK, Dixit Y, Siddaramaiah NH, Seth P, Pande JN. HIV seropositivity among adult tuberculosis patients in Delhi. Indian Journal of Chest Diseases and Allied Sciences. 2000 Jul 1;42(3):157-60.
  6. Pontus Nordenfelt, Collin M. Bacterial Pathogenesis. Springer Nature; 2023. https://www.who.int/publications/i/item/9789240037021
  7. Tripathi S, Joshi DR, Mehendale SM, Menon P, Joshi AN, Ghorpade SV, Patil U, Paranjape BS. Sentinel surveillance for HIV infection in tuberculosis patients in India. Indian Journal of Tuberculosis. 2002 Sep 11;49(1):17-20.
  8. Vaidyanathan PS, Singh S. TB-HIV co-infection in India. NTI Bulletin. 2003;39(3):11-8.
  9. Khare, K. C. “HIV seropositivity in pulmonary tuberculosis patients in Indore, Madhya Pradesh.” (2001): 153.
  10. Vaidyanathan PS, Singh S. TB-HIV co-infection in India. NTI Bulletin. 2003;39(3):11-8.
  11. Rajasekaran, S., A. Uma, S. Kamakshi, D. Jeyaganesh, A. Senthamizhchelvan, S. Savithri, and Gopinathan Gopinathan. “Trend of HIV infection in patients with tuberculosis in rural south India.” (2000): 223-226.
  12. Zuber Ahmad, Zuber Ahmad, Rakesh Bhargava Rakesh Bhargava, D. K. Pandey, and K. Sharma. “HIV infection seroprevalence in tuberculosis patients.” (2003): 151-154.
  13. Mohanty, K. C., and P. M. M. Basheer. “Changing trend of HIV infection and tuberculosis in a Bombay area since 1988.” (1995): 117-120.
  14. Paranjape RS, Tripathy SP, Menon PA, Mehendale SM, Khatavkar P, Joshi DR, Patil U, Gadkari DA, Rodrigues JJ. Increasing trend of HIV seroprevalence among pulmonary tuberculosis patients in Pune, India. Indian journal of medical research. 1997 Sep 1;106:207-11.
  15. Tripathy SP, Joshi DR, Menon P, Paranjpe RS, Mehendale SM, Khatavkar P. Seroprevalence of HIV-1 infection in tuberculosis patients at Pune. InXI International conference on AIDS. Vancouver Canada July 1996 (pp. 7-12).
  16. Solomon S, Anuradha S, Rajasekaran S. Trend of HIV infection in patients with pulmonary tuberculosis in south India. Tubercle and Lung disease. 1995 Feb 1;76(1):17-9.
  17. Samuel NM, Alamelu C, Jagannath K, Rajan B. Detection of HIV infection in pulmonary tuberculosis patients. Journal of the Indian Medical Association. 1996 Sep 1;94(9):331-3.
  18. Harries AD, Kumar AM, Kyaw NT, Hoa NB, Takarinda KC, Zachariah R. The role of antiretroviral therapy in reducing TB incidence and mortality in high HIV-TB burden countries. Asian Pacific journal of tropical disease. 2016 Mar 1;6(3):243-7.
  19. Talib SH, Bansal MP, Kamble MM. HIV-1 seropositivity in pulmonary tuberculosis (study of 340 cases from Marathwada). Indian Journal of Pathology & Microbiology. 1993 Oct 1;36(4):383-8.
  20. Banavaliker, J. N., Ritu Gupta, D. C. Sharma, Manoj K. Goel, and S. Kumari. “HIV seropositivity in hospitalised pulmonary tuberculosis patients in Delhi.” (1997): 17-20.
  21. Vaidyanathan PS, Singh S. TB-HIV co-infection in India. NTI Bulletin. 2003;39(3):11-8.
  22. World Health Organization. A deadly partnership. Tuberculosis in the era of HIV. Global Tuberculosis Programme. World Health Organization publication (Geneva) WHO/TB/96204. 2015.
  23. Sharma N, Khanna A, Chandra S, Basu S, Bajaj D, Sachdeva KS, Ramachandran R. Tuberculosis (TB) intervention model targeting mobile population of truckers in Delhi, India. Indian Journal of Tuberculosis. 2019 Jul 1;66(3):382-7.
  24. Training manual on intensified TB/HIV package for medical officers, CTD and NACO, Ministry of Health and Family Welfare, Government of India.June,2008, pp 1-18.
  25. Kundu D, Chopra K, Khanna A, Babbar N, Padmini TJ. Accelerating TB notification from the private health sector in Delhi, India. indian journal of tuberculosis. 2016 Jan 1;63(1):8-12.
  26. Misra S, Goli S, Rana MJ, Gautam A, Datta N, Nanda P, Verma R. Family welfare expenditure, contraceptive use, sources and method-mix in India. Sustainability. 2021 Aug 25;13(17):9562.
  27. Menon GR, Singh L, Sharma P, Yadav P, Sharma S, Kalaskar S, Singh H, Adinarayanan S, Joshua V, Kulothungan V, Yadav J. National Burden Estimates of healthy life lost in India, 2017: an analysis using direct mortality data and indirect disability data. The Lancet Global Health. 2019 Dec 1;7(12):e1675-84.
Ahead of Print Subscription Review Article
Volume 15
02
Received 02/02/2025
Accepted 28/02/2025
Published 28/02/2025
Publication Time 26 Days
108

async function fetchCitationCount(doi) {
let apiUrl = `https://api.crossref.org/works/${doi}`;
try {
let response = await fetch(apiUrl);
let data = await response.json();
let citationCount = data.message[“is-referenced-by-count”];
document.getElementById(“citation-count”).innerText = `Citations: ${citationCount}`;
} catch (error) {
console.error(“Error fetching citation count:”, error);
document.getElementById(“citation-count”).innerText = “Citations: Data unavailable”;
}
}
fetchCitationCount(“10.37591/RRJoMV.v15i02.0”);

Loading citations…